Uveo Europe

About Uveo Europe

Uveo utilizes disinfection light technology to continuously eliminate viruses and bacteria in healthcare and workplace environments, achieving an equivalent of at least 36 air exchanges per hour. This technology significantly reduces healthcare-associated infections (HAIs) and enhances hygiene safety in clinics and surgical settings.

```xml <problem> Healthcare facilities and workplaces face the persistent challenge of airborne and surface contamination from viruses and bacteria, leading to healthcare-associated infections (HAIs) and increased employee absenteeism. Traditional disinfection methods often rely on manual cleaning and chemical disinfectants, which may not provide continuous protection and can have environmental drawbacks. </problem> <solution> Uveo provides continuous disinfection solutions using Far UV-C 222nm light technology, proven effective against a broad spectrum of pathogens, including viruses and bacteria, in both air and on surfaces. The technology utilizes a patented optical filter to ensure safe human exposure, enabling continuous operation in occupied spaces. Uveo's disinfection lighting systems offer an automated, chemical-free approach to reducing the spread of infections, improving hygiene safety, and minimizing disruptions to daily operations. The systems are designed for easy integration into various environments, providing an added layer of protection beyond standard cleaning protocols. </solution> <features> - Employs Far UV-C 222nm light with a patented optical filter for safe use in occupied spaces. - Provides continuous disinfection of both air and surfaces, reducing the spread of infectious agents. - Inactivates up to 99.9% of viruses, bacteria, and other pathogenic microorganisms. - Offers a chemical-free disinfection alternative, minimizing environmental impact. - Features automated operation, requiring no manual intervention or changes to existing routines. - Can be easily installed in diverse settings, including healthcare facilities, offices, and public transportation. - Designed with advanced algorithms to maximize disinfection efficiency while ensuring exposure levels remain within regulated safety standards. </features> <target_audience> Uveo's primary customers include hospitals, healthcare clinics, elder care facilities, offices, and transportation providers seeking to enhance hygiene, reduce infection rates, and create safer environments for patients, employees, and the public. </target_audience> ```

What does Uveo Europe do?

Uveo utilizes disinfection light technology to continuously eliminate viruses and bacteria in healthcare and workplace environments, achieving an equivalent of at least 36 air exchanges per hour. This technology significantly reduces healthcare-associated infections (HAIs) and enhances hygiene safety in clinics and surgical settings.

Where is Uveo Europe located?

Uveo Europe is based in Stockholm, Sweden.

When was Uveo Europe founded?

Uveo Europe was founded in 2022.

Who founded Uveo Europe?

Uveo Europe was founded by Jesper Liljegren.

  • Jesper Liljegren - Product Manager and Founder
Location
Stockholm, Sweden
Founded
2022
Employees
4 employees
Looking for specific startups?
Try our free semantic startup search

Uveo Europe

Score: 35/100
AI-Generated Company Overview (experimental) – could contain errors

Executive Summary

Uveo utilizes disinfection light technology to continuously eliminate viruses and bacteria in healthcare and workplace environments, achieving an equivalent of at least 36 air exchanges per hour. This technology significantly reduces healthcare-associated infections (HAIs) and enhances hygiene safety in clinics and surgical settings.

uveo.se300+
Founded 2022Stockholm, Sweden

Funding

No funding information available. Click "Fetch funding" to run a targeted funding scan.

Team (<5)

Jesper Liljegren

Product Manager and Founder

Company Description

Problem

Healthcare facilities and workplaces face the persistent challenge of airborne and surface contamination from viruses and bacteria, leading to healthcare-associated infections (HAIs) and increased employee absenteeism. Traditional disinfection methods often rely on manual cleaning and chemical disinfectants, which may not provide continuous protection and can have environmental drawbacks.

Solution

Uveo provides continuous disinfection solutions using Far UV-C 222nm light technology, proven effective against a broad spectrum of pathogens, including viruses and bacteria, in both air and on surfaces. The technology utilizes a patented optical filter to ensure safe human exposure, enabling continuous operation in occupied spaces. Uveo's disinfection lighting systems offer an automated, chemical-free approach to reducing the spread of infections, improving hygiene safety, and minimizing disruptions to daily operations. The systems are designed for easy integration into various environments, providing an added layer of protection beyond standard cleaning protocols.

Features

Employs Far UV-C 222nm light with a patented optical filter for safe use in occupied spaces.

Provides continuous disinfection of both air and surfaces, reducing the spread of infectious agents.

Inactivates up to 99.9% of viruses, bacteria, and other pathogenic microorganisms.

Offers a chemical-free disinfection alternative, minimizing environmental impact.

Features automated operation, requiring no manual intervention or changes to existing routines.

Can be easily installed in diverse settings, including healthcare facilities, offices, and public transportation.

Designed with advanced algorithms to maximize disinfection efficiency while ensuring exposure levels remain within regulated safety standards.

Target Audience

Uveo's primary customers include hospitals, healthcare clinics, elder care facilities, offices, and transportation providers seeking to enhance hygiene, reduce infection rates, and create safer environments for patients, employees, and the public.

Uveo Europe | StartupSeeker